Glioma patients can now expect a longer, healthier lifespan
Glioma Overview Low-grade glioma, also known as grade 2 glioma, generally affect young adults. The pathophysiology gradually leads to...
MDforLives
New breakthrough in pain management helps relieve ‘Backache’ significantly
Around 23% to 26% of the total population suffers from a chronic backache. This chronic pain impairs the person...
First-line therapy with avelumab in patients with advanced NSCLC is found to have clinical activity
Lung cancer is the second most common cancer in both men and women (excluding skin cancer). It is the...
FDA Approves Epclusa: A New Drug That Treats All Genotypes Of Hepatitis C Infection
US Food and Drug Administration has approved Epclusa an oral, fixed-dose combination drug for adults, containing sofosbuvir 400 mg...
FDA Approves Balloon Dilatation For Eustachian Tube Dysfunction
The US Food and Drug Administration has now permitted sale of a device that uses a small balloon to...
Adjuvant therapy with Sutent® extends disease-free survival in high risk renal cell carcinoma patients
Renal cell carcinoma (RCC) is one of the most common types of kidney cancer. It is diagnosed annually in...
FDA ALERT REGARDING RISKS ASSOCIATED WITH OVARIAN CANCER SCREENING TESTS
Ovarian cancer is the sixth most commonly diagnosed cancer worldwide. Second, only to uterine cancer, it is a leading...
First-line therapy with avelumab in patients with advanced NSCLC is found to have clinical activity
Lung cancer is the second most common cancer in both men and women (excluding skin cancer). It is the...
FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...
Zika virus: Current global status, threats and concerns
Zika virus discovered in Uganda in 1947 is currently making the world headlines for its outbreak in South America...